The Filings Report

DaVita Inc.

DVANYSECIK 927066Healthcare / Healthcare Providers & Servicesfiscal year ends December74 quarters since 2008

Revenue, Q3 FY2026
$3.6B
+4.6% on Q3 FY2025
Net income
$223M
+48.3% on Q3 FY2025
Free cash flow
$359M
−46.8% on Q3 FY2025
Diluted EPS
$3.40
+66.7% on Q3 FY2025
Revenue, TTM
$14.2B
trailing four quarters
Net margin, TTM
6.5%
net income $920M
Free cash flow, TTM
$1.3B
$1.9B less $577M capex
Cash and equivalents
$496M
long-term debt —, Sep 30, 2026
Shares, 12-month change
−10.9%
63M shares, Sep 30, 2026
Buybacks, TTM
$725M
6.2% of market value
Dividends, TTM
—
no yield
Market value
$11.7B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 29, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, DaVita Inc. reported revenue of $3.6B, +4.6% on Q3 FY2025, and net income of $223M (+48.3%). Operating margin was 14.0%. Free cash flow, operating cash flow less capital expenditures, was $359M ($519M less $159M). Diluted earnings per share were $3.40.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 29, 2026.

Revenue and net incomeRevenueNet income
$0$1B$2B$3B$4BQ4'22, Revenue: $2.9BQ4'22, Net income: $68MQ4'22Q1'23, Revenue: $2.9BQ1'23, Net income: $116MQ1'23Q2'23, Revenue: $3.0BQ2'23, Net income: $179MQ2'23Q3'23, Revenue: $3.1BQ3'23, Net income: $247MQ3'23Q4'23, Revenue: $3.1BQ4'23, Net income: $151MQ4'23Q1'24, Revenue: $3.1BQ1'24, Net income: $240MQ1'24Q2'24, Revenue: $3.2BQ2'24, Net income: $223MQ2'24Q3'24, Revenue: $3.3BQ3'24, Net income: $215MQ3'24Q4'24, Revenue: $3.3BQ4'24, Net income: $259MQ4'24Q1'25, Revenue: $3.2BQ1'25, Net income: $163MQ1'25Q2'25, Revenue: $3.4BQ2'25, Net income: $199MQ2'25Q3'25, Revenue: $3.4BQ3'25, Net income: $150MQ3'25Q4'25, Revenue: $3.6BQ4'25, Net income: $234MQ4'25Q1'26, Revenue: $3.4BQ1'26, Net income: $198MQ1'26Q2'26, Revenue: $3.6BQ2'26, Net income: $265MQ2'26Q3'26, Revenue: $3.6BQ3'26, Net income: $223MQ3'26$0$1B$2B$3B$4BQ4'22, Revenue: $2.9BQ4'22, Net income: $68MQ1'23, Revenue: $2.9BQ1'23, Net income: $116MQ1'23Q2'23, Revenue: $3.0BQ2'23, Net income: $179MQ3'23, Revenue: $3.1BQ3'23, Net income: $247MQ3'23Q4'23, Revenue: $3.1BQ4'23, Net income: $151MQ1'24, Revenue: $3.1BQ1'24, Net income: $240MQ1'24Q2'24, Revenue: $3.2BQ2'24, Net income: $223MQ3'24, Revenue: $3.3BQ3'24, Net income: $215MQ3'24Q4'24, Revenue: $3.3BQ4'24, Net income: $259MQ1'25, Revenue: $3.2BQ1'25, Net income: $163MQ1'25Q2'25, Revenue: $3.4BQ2'25, Net income: $199MQ3'25, Revenue: $3.4BQ3'25, Net income: $150MQ3'25Q4'25, Revenue: $3.6BQ4'25, Net income: $234MQ1'26, Revenue: $3.4BQ1'26, Net income: $198MQ1'26Q2'26, Revenue: $3.6BQ2'26, Net income: $265MQ3'26, Revenue: $3.6BQ3'26, Net income: $223MQ3'26

Net income losses drawn in red.

Free cash flow
−$500M−$250M$0$250M$500M$750MQ4'22, Free cash flow: $150MQ4'22Q1'23, Free cash flow: $315MQ1'23Q2'23, Free cash flow: $326MQ2'23Q3'23, Free cash flow: $524MQ3'23Q4'23, Free cash flow: $326MQ4'23Q1'24, Free cash flow: −$256MQ1'24Q2'24, Free cash flow: $674MQ2'24Q3'24, Free cash flow: $671MQ3'24Q4'24, Free cash flow: $377MQ4'24Q1'25, Free cash flow: $37MQ1'25Q2'25, Free cash flow: $203MQ2'25Q3'25, Free cash flow: $675MQ3'25Q4'25, Free cash flow: $395MQ4'25Q1'26, Free cash flow: $219MQ1'26Q2'26, Free cash flow: $320MQ2'26Q3'26, Free cash flow: $359MQ3'26−$500M−$250M$0$250M$500M$750MQ4'22, Free cash flow: $150MQ1'23, Free cash flow: $315MQ1'23Q2'23, Free cash flow: $326MQ3'23, Free cash flow: $524MQ3'23Q4'23, Free cash flow: $326MQ1'24, Free cash flow: −$256MQ1'24Q2'24, Free cash flow: $674MQ3'24, Free cash flow: $671MQ3'24Q4'24, Free cash flow: $377MQ1'25, Free cash flow: $37MQ1'25Q2'25, Free cash flow: $203MQ3'25, Free cash flow: $675MQ3'25Q4'25, Free cash flow: $395MQ1'26, Free cash flow: $219MQ1'26Q2'26, Free cash flow: $320MQ3'26, Free cash flow: $359MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$500M$1.0B$1.5BQ4'22, Cash and equivalents: $244MQ4'22Q1'23, Cash and equivalents: $317MQ1'23Q2'23, Cash and equivalents: $327MQ2'23Q3'23, Cash and equivalents: $449MQ3'23Q4'23, Cash and equivalents: $380MQ4'23Q1'24, Cash and equivalents: $345MQ1'24Q2'24, Cash and equivalents: $416MQ2'24Q3'24, Cash and equivalents: $1.1BQ3'24Q4'24, Cash and equivalents: $795MQ4'24Q1'25, Cash and equivalents: $439MQ1'25Q2'25, Cash and equivalents: $708MQ2'25Q3'25, Cash and equivalents: $706MQ3'25Q4'25, Cash and equivalents: $676MQ4'25Q1'26, Cash and equivalents: $644MQ1'26Q2'26, Cash and equivalents: $669MQ2'26Q3'26, Cash and equivalents: $496MQ3'26$0$500M$1.0B$1.5BQ4'22, Cash and equivalents: $244MQ1'23, Cash and equivalents: $317MQ1'23Q2'23, Cash and equivalents: $327MQ3'23, Cash and equivalents: $449MQ3'23Q4'23, Cash and equivalents: $380MQ1'24, Cash and equivalents: $345MQ1'24Q2'24, Cash and equivalents: $416MQ3'24, Cash and equivalents: $1.1BQ3'24Q4'24, Cash and equivalents: $795MQ1'25, Cash and equivalents: $439MQ1'25Q2'25, Cash and equivalents: $708MQ3'25, Cash and equivalents: $706MQ3'25Q4'25, Cash and equivalents: $676MQ1'26, Cash and equivalents: $644MQ1'26Q2'26, Cash and equivalents: $669MQ3'26, Cash and equivalents: $496MQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

DaVita Inc. income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 11, 2026Q3 FY2025ended Sep 30, 2025filed Oct 29, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 12, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue3,5783,5543,4163,6203,4203,3803,2243,295+4.6%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative409423422472414413374414−1.4%
Operating income499579482561506538439565−1.3%
Other income (expense)984(21)(41)(23)(18)(13)+122.9%
Pretax income359435341383309369286414+16.2%
Income tax8992667769945464+30.3%
Net income223265198234150199163259+48.3%
Diluted EPS ($)3.404.022.87—2.042.582.00—+66.7%
Diluted shares (millions)666669—747781——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

DaVita Inc. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 11, 2026Q3 FY2025ended Sep 30, 2025filed Oct 29, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 12, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents496669644676706708439795−29.8%
Short-term investments7120222431317351+131.5%
Total current assets4,0754,1904,0634,0584,1124,0883,6363,746−0.9%
Total assets17,81717,70917,49917,48017,55617,49317,11917,285+1.5%
Total current liabilities2,8872,8552,8673,1423,0172,9342,9072,973−4.3%
Long-term debt—————————
Total liabilities16,69116,63016,45116,32216,21515,94015,45915,194+2.9%
Stockholders’ equity(591)(765)(755)(651)(572)(370)(267)121−3.4%
Shares outstanding (millions)6364646771727680—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

DaVita Inc. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 11, 2026Q3 FY2025ended Sep 30, 2025filed Oct 29, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 12, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow519490321541842324180548−38.3%
Capital expenditures159170102145166121143171−4.0%
Free cash flow (CFO − capex)35932021939567520337377−46.8%
Depreciation and amortization165168178180177175176167−6.9%
Share repurchases73181196274240284510365−69.6%
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 11, 2026.

Income statement

DaVita Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 11, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 14, 2024FY2022ended Dec 31, 2022filed Feb 22, 2023FY2021ended Dec 31, 2021filed Feb 11, 2022FY2020ended Dec 31, 2020filed Feb 12, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 23, 2018FY2016ended Dec 31, 2016filed Feb 24, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 21, 2014FY2012ended Dec 31, 2012filed Mar 1, 2013FY2011ended Dec 31, 2011filed Feb 24, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Feb 25, 2010FY2008ended Dec 31, 2008filed Aug 7, 2009FY2007ended Dec 31, 2007filed Aug 7, 2009
Revenue13,64312,81612,14011,61011,61911,55111,38811,40510,87710,707—————————
Cost of revenue———————————————————
Gross profit———————————————————
Research and development———————————————————
Selling, general and administrative1,6741,5381,4741,3551,1951,2481,1031,1351,0641,0731,0311,2621,176890685572532508491
Operating income2,0442,0901,6031,3391,7971,6951,6431,5261,8132,0301,1371,8151,5501,2971,155994940869909
Other income (expense)(103)(70)(19)(16)617291018882543————
Pretax income1,3471,5301,1779661,5181,3181,1951,0481,4001,6236881,3101,1251,001917741758657674
Income tax293280220198307314280258324432208446381360325259278235246
Net income747936692560978774811159664880270723633536478406423374382
Diluted EPS ($)9.8410.737.425.858.906.315.270.923.474.291.253.332.952.742.481.97*2.03*1.76*1.77*
Diluted shares (millions)76879396110123154172191205216217215196193206*208*212*215*

Balance sheet

DaVita Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 11, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 14, 2024FY2022ended Dec 31, 2022filed Feb 22, 2023FY2021ended Dec 31, 2021filed Feb 11, 2022FY2020ended Dec 31, 2020filed Feb 12, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 23, 2018FY2016ended Dec 31, 2016filed Feb 24, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 21, 2014FY2012ended Dec 31, 2012filed Mar 1, 2013FY2011ended Dec 31, 2011filed Feb 24, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Feb 25, 2010FY2008ended Dec 31, 2008filed Aug 7, 2009FY2007ended Dec 31, 2007filed Aug 7, 2009
Cash and equivalents6767953802444623251,1023235086751,245737946534394860539411447
Short-term investments245112782220123333074083377717232636—
Total current assets4,0583,7463,1383,1553,1683,1493,6908,4248,7713,9954,5033,6363,4722,8872,2932,6232,3032,128—
Total assets17,48017,28516,89416,92817,12116,98917,31119,11018,97518,75618,51517,61717,09916,0158,9048,1147,5587,286—
Total current liabilities3,1422,9732,6422,6202,3992,4762,3724,8913,0682,7112,3992,0892,4622,0161,1659241,0471,163—
Long-term debt———————————8,5038,4168,5544,5054,2343,5323,622—
Total liabilities16,32215,19414,15014,70314,75114,09213,81214,07713,07712,93312,56711,42711,79611,5176,1575,6945,0325,168—
Stockholders’ equity(651)1211,0567127561,3842,1333,7034,6904,6484,8715,1714,4323,7632,1411,9782,1351,768—
Shares outstanding (millions)6780889096109126166182195206216213211*187*192*206*——

Cash flow statement

DaVita Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 11, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 14, 2024FY2022ended Dec 31, 2022filed Feb 22, 2023FY2021ended Dec 31, 2021filed Feb 11, 2022FY2020ended Dec 31, 2020filed Feb 12, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 23, 2018FY2016ended Dec 31, 2016filed Feb 24, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 21, 2014FY2012ended Dec 31, 2012filed Mar 1, 2013FY2011ended Dec 31, 2011filed Feb 24, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Feb 25, 2010FY2008ended Dec 31, 2008filed Aug 7, 2009FY2007ended Dec 31, 2007filed Aug 7, 2009
Operating cash flow1,8872,0222,0591,5651,9311,9792,0721,7721,9131,9721,5571,4591,7731,1011,180840667614581
Capital expenditures576555568603641675767987905829708641618550400274275318272
Free cash flow (CFO − capex)1,3111,4671,4919611,2891,3041,3067851,0081,1438498181,156551780566392296309
Depreciation and amortization708716736721668617601575544495445428373300248218214201193
Share repurchases1,3081,3862728021,5391,4582,3841,1628031,098550———3236181532336
Dividends paid00000000———————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 3, 2024 to November 3, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$69M
1 sales by 1 insider; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$523M
13 sales by 7 insiders; officers and directors $35M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 27, 2026Berkshire Hathaway INC+1 more10% owneropen-market saleindirect382,563$180.43$69M28MOct 29, 2026
Sep 22, 2026Maughan David PaulChief Operating Officer, DKCtax withholding7,501$182.34$1M86,604Sep 24, 2026
Aug 15, 2026Hollar Jason M.Directoraward278$0.00—6,883Aug 18, 2026
Aug 15, 2026Desoer Barbara JDirectoraward278$0.00—278Aug 18, 2026
Aug 15, 2026Schechter Adam HDirectoraward278$0.00—5,970Aug 18, 2026
Aug 15, 2026Moore Gregory J.Directoraward278$0.00—8,091Aug 18, 2026
Aug 15, 2026Pullin Dennis WDirectoraward278$0.00—2,949Aug 18, 2026
Aug 15, 2026Schoppert Wendy LeeDirectoraward278$0.00—278Aug 18, 2026
Aug 15, 2026Arway Pamela MDirectoraward278$0.00—27,223Aug 18, 2026
Aug 15, 2026Yale Phyllis RDirectoraward278$0.00—9,803Aug 18, 2026
Jul 31, 2026Berkshire Hathaway INC+1 more10% owneropen-market saleindirect182,980$199.55$37M29MAug 4, 2026
Jun 16, 2026Rodriguez JavierChief Executive Officer, Directoropen-market sale39,407$209.28$8M840,408Jun 17, 2026
Jun 15, 2026Waters Kathleen AlyceChief Legal & Pub. Affairs Offopen-market sale8,950$207.84$2M115,649Jun 17, 2026
Jun 15, 2026Waters Kathleen AlyceChief Legal & Pub. Affairs Offopen-market sale6,455$209.17$1M109,194Jun 17, 2026
Jun 15, 2026Rodriguez JavierChief Executive Officer, Directoropen-market sale30,000$209.50$6M879,815Jun 17, 2026
May 26, 2026Yale Phyllis RDirectorgift5,038$0.00—9,525May 28, 2026
May 15, 2026Pullin Dennis WDirectoraward250$0.00—2,671May 18, 2026
May 15, 2026Moore Gregory J.Directoraward250$0.00—7,813May 18, 2026
May 15, 2026Schoppert Wendy LeeDirectoraward250$0.00—250May 18, 2026
May 15, 2026Arway Pamela MDirectoraward250$0.00—26,945May 18, 2026
May 15, 2026Yale Phyllis RDirectoraward250$0.00—14,563May 18, 2026
May 15, 2026Desoer Barbara JDirectoraward250$0.00—250May 18, 2026
May 15, 2026Schechter Adam HDirectoraward250$0.00—5,692May 18, 2026
May 15, 2026Hollar Jason M.Directoraward250$0.00—6,605May 18, 2026
May 15, 2026Hearty James OChief Compliance Officeropen-market sale15,000$193.98$3M22,389May 18, 2026

Full insider history for DaVita Inc., or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held DVA in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded DVA by quarter.

FundManagerQuarterValueSharesWeightMove
Berkshire HathawayWarren BuffettQ2 2026$6.4B29M2.15%trimmed −4.1%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
DAVITA INC., CIK 927066 on EDGAR
Extract generated
November 4, 2026
Withheld
3 line-years whose four quarters do not sum to the filed year: operating income FY2015, pretax income FY2015, depreciation amortization FY2017
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent, ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAmortizationAndAccretionNet, DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 4, 2026.

JSON file
/data/financials/DVA.json